125 related articles for article (PubMed ID: 6241825)
21. The effect of an iron (III) chelator, silybin, on the proliferation and cell cycle of Jurkat cells: a comparison with desferrioxamine.
Gharagozloo M; Khoshdel Z; Amirghofran Z
Eur J Pharmacol; 2008 Jul; 589(1-3):1-7. PubMed ID: 18619590
[TBL] [Abstract][Full Text] [Related]
22. Stimulation of T-cell proliferation by pancreastatin and its C-terminal fragment (33-49).
Haberstock-Debic H; Banfic H; Stevens WJ; De Clerck LS; Wechsung E; De Potter W
Neuroimmunomodulation; 1997; 4(5-6):244-9. PubMed ID: 9650817
[TBL] [Abstract][Full Text] [Related]
23. [Relations between concanavalin A binding and cell proliferation. Comparison of Lyt-1+ and Lyt-2+ lymphocyte subpopulations from the spleen of unstimulated mice and mixed lymphocyte culture].
Hückel C; Kusnierczyk P; Jenssen HL; Pajtasz E; Brock J
Allerg Immunol (Leipz); 1987; 33(2):71-8. PubMed ID: 2959128
[TBL] [Abstract][Full Text] [Related]
24. The effect of drugs used in anticoagulation therapy on T lymphocyte activation in vitro. II. Warfarin inhibits T lymphocyte activation.
Bruserud O; Lundin K
J Clin Lab Immunol; 1987 Aug; 23(4):169-73. PubMed ID: 2959784
[TBL] [Abstract][Full Text] [Related]
25. Immune depression in trypanosome-infected mice. I. Depressed T lymphocyte responses.
Pearson TW; Roelants GE; Lundin LB; Mayor-Withey KS
Eur J Immunol; 1978 Oct; 8(10):723-7. PubMed ID: 152204
[TBL] [Abstract][Full Text] [Related]
26. Mitogenic response of marmoset lymphocytes: cytokinetics and identification of responsive cells.
Kateley JR; Nickerson DA; Gengozian N
Immunology; 1977 Nov; 33(5):653-662. PubMed ID: 145405
[TBL] [Abstract][Full Text] [Related]
27. Interference with oxidative processes inhibits proliferation of human peripheral blood lymphocytes and murine B-lymphocytes.
Hunt NH; Cook EP; Fragonas JC
Int J Immunopharmacol; 1991; 13(7):1019-26. PubMed ID: 1761347
[TBL] [Abstract][Full Text] [Related]
28. Glycine inhibits growth of T lymphocytes by an IL-2-independent mechanism.
Stachlewitz RF; Li X; Smith S; Bunzendahl H; Graves LM; Thurman RG
J Immunol; 2000 Jan; 164(1):176-82. PubMed ID: 10605009
[TBL] [Abstract][Full Text] [Related]
29. Iron-containing proteins augment responses of human lymphocytes to phytohemagglutinin and pokeweek mitogen in serum-free medium.
Tanno Y; Arai S; Takishima T
Tohoku J Exp Med; 1982 Jul; 137(3):335-43. PubMed ID: 7112553
[TBL] [Abstract][Full Text] [Related]
30. The role of reactive oxygen species in triggering proliferation and IL-2 secretion in T cells.
Tatla S; Woodhead V; Foreman JC; Chain BM
Free Radic Biol Med; 1999 Jan; 26(1-2):14-24. PubMed ID: 9890636
[TBL] [Abstract][Full Text] [Related]
31. T cell proliferation in the mixed lymphocyte culture does not necessarily result in the generation of cytotoxic T effector cells.
Röllinghoff M; Pfizenmeier K; Trostmann H; Wagner H
Eur J Immunol; 1975 Aug; 5(8):560-4. PubMed ID: 135689
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of lymphocyte proliferation by the anti-arthritic drug sinomenine.
Liu L; Resch K; Kaever V
Int J Immunopharmacol; 1994 Aug; 16(8):685-91. PubMed ID: 7989137
[TBL] [Abstract][Full Text] [Related]
33. Migration inhibition factor and blast transformation in human lymphoid cultures stimulated by different agents.
Dimitriu A; Dy M; Thomson N; Bona C
Clin Exp Immunol; 1974 Sep; 18(1):141-8. PubMed ID: 4619594
[TBL] [Abstract][Full Text] [Related]
34. The in vitro response of human tumour cells to desferrioxamine is growth medium dependent.
Voest EE; Rooth H; Neijt JP; van Asbeck BS; Marx JJ
Cell Prolif; 1993 Jan; 26(1):77-88. PubMed ID: 8439591
[TBL] [Abstract][Full Text] [Related]
35. Effects of C-reactive protein on the lymphoid system. II. Inhibition of mixed lymphocyte reactivity and generation of cytotoxic lymphocytes.
Mortensen RF; Gewurz H
J Immunol; 1976 May; 116(5):1244-50. PubMed ID: 131842
[TBL] [Abstract][Full Text] [Related]
36. Induction of suppressor activity in the autologous mixed lymphocyte reaction and in cultures with concanavalin A.
Innes JB; Kuntz MM; Kim YT; Weksler ME
J Clin Invest; 1979 Dec; 64(6):1608-13. PubMed ID: 159315
[TBL] [Abstract][Full Text] [Related]
37. Cellular interactions in the proliferative response of human T and B lymphocytes to phytomitogens and allogeneic lymphocytes.
Lohrmann HP; Novikovs L; Graw RG
J Exp Med; 1974 Jun; 139(6):1553-67. PubMed ID: 4598019
[TBL] [Abstract][Full Text] [Related]
38. Desferrioxamine treatment prevents chronic islet allograft damage.
Bradley B; Prowse SJ; Bauling P; Lafferty KJ
Diabetes; 1986 May; 35(5):550-5. PubMed ID: 3082702
[TBL] [Abstract][Full Text] [Related]
39. Role of interleukin 2 on enhancement of concanavalin A-induced human peripheral blood lymphocyte proliferation by murine B cell mitogens.
Nitta T; Konno-Ejiri H; Okumura S; Ozawa A; Nakano M
Microbiol Immunol; 1985; 29(5):441-9. PubMed ID: 3875780
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of human lymphocyte transformation by human alpha-fetoprotein (HAFP); HAFP monomers and multimers and a resistant lymphocyte subpopulation.
Yachnin S; Lester EP
J Immunol; 1977 Aug; 119(2):555-7. PubMed ID: 69662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
